M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_12203

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_12203 8 0.17 Mlig455_061049

Neo: -

Age: -

 Mlig455_061049 {REF} {Length: 1492} {RNA1509_16662} {RNA1310_122445} {RNA815_4833.1}

Cumulative graph for MligTC455_12203

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 - - - -
RegionR2 - - - -
RegionR3 - - - -
RegionR4 - - - -
RegionR5 - - - -
RegionR6 - - - -
RegionR7 - - - -
RegionR8 - - - -

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 - - - -
RegenerationR2 - - - -
RegenerationR3 - - - -
RegenerationR4 - - - -
RegenerationR5 - - - -
RegenerationR6 - - - -
RegenerationBL - - - -
RegenerationTP - - - -


Genes with expression patterns similar to MligTC455_12203

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_12203 8 0.17 Mlig455_061049

Neo: -

Age: -

 2 - - - - 1.000 1.000 Mlig455_061049 {REF} {Length: 1492} {RNA1509_16662} {RNA1310_122445} {RNA815_4833.1}
2. MligTC455_22853 33 0.7 Mlig455_019405, Mlig455_059068

Neo: -

Age: -

 1.707 - - - - 0.976 0.731

Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811}

Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811}
3. MligTC455_23922 8 0.17 Mlig455_001765

Neo: -

Age: Down-Up-Down

 0.992 - - - - 0.992 - Mlig455_001765 {REF} {Length: 4721} {Pfam: AMP-binding enzyme [PF00501.30, score=68.9]} {RNA1509_37800} {RNA1310_40483} {RNA815_30709}
4. MligTC455_14578 33 0.69 Mlig455_033066

Neo: -

Age: -

 0.991 - - - - 0.991 - Mlig455_033066 {REF} {Length: 2292} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.2]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=63.9, Expect=1e-10]} {RNA1310_28762} {RNA815_42177}
5. MligTC455_14604 21 0.43 Mlig455_014269

Neo: -

Age: -

 0.986 - - - - 0.986 - Mlig455_014269 {REF} {Length: 2720} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=90.5]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=108, Expect=3e-25]} {RNA1310_19428.1} {RNA815_22602}
6. MligTC455_50029 35 0.74 Mlig455_010619, Mlig455_010708

Neo: -

Age: -

 FOXA1 0.984 - - - - 0.984 -

Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]}

Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]}
7. MligTC455_53285 6 0.13 Mlig455_061305

Neo: -

Age: -

 0.984 - - - - 0.984 - Mlig455_061305 {REF} {Length: 422} {NoTransDecoderORF}
8. MligTC455_54226 52 1.09 Mlig455_037435, Mlig455_037458

Neo: -

Age: -

 NETO2 0.984 - - - - 0.984 -

Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111}

Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111}
9. MligTC455_09686 4 0.08 Mlig455_061629

Neo: -

Age: -

 0.983 - - - - 0.983 - Mlig455_061629 {REF} {Length: 1698} {NoTransDecoderORF} {RNA1509_20320} {RNA1310_104302} {RNA815_52785.1}
10. MligTC455_31212 97 2.02 Mlig455_028599, Mlig455_056911

Neo: -

Age: -

 0.983 - - - - 0.983 -

Mlig455_028599 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362}

Mlig455_056911 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362}
11. MligTC455_19171 162 3.38 Mlig455_047844

Neo: -

Age: -

 LRRD1 0.982 - - - - 0.982 - Mlig455_047844 {REF} {Length: 3483} {Pfam: Leucine rich repeat [PF13855.8, score=200.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=161.9]; Leucine-rich repeat [PF14580.8, score=62.9]; Death domain [PF00531.24, score=25.2]; RsmF rRNA methyltransferase first C-terminal domain [PF17126.7, score=19.3]} {Human: ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [RH, Score=265, Expect=2e-76]} {Mouse: ENSMUSG00000040367, Lrrd1, leucine rich repeats and death domain containing 1, [RH, Score=305, Expect=1e-91]} {Dmel: FBgn0038504, Sur-8, [Score=157, Expect=3e-40]} {Celegans: WBGene00004929, soc-2, Leucine-rich repeat protein soc-2, [Score=151, Expect=1e-38]} {Smed: dd_Smed_v6_10136_0_1, dd_Smed_v6_10136_0_1, [RH, Score=281, Expect=6e-85]} {RNA1509_11343, RNA1509_19633} {RNA1310_7039.2, RNA1509_11343} {RNA1509_11343, RNA815_1369.1}
12. MligTC455_18262 28 0.59 Mlig455_023697

Neo: -

Age: Down-Up-Down

 0.981 - - - - 0.981 - Mlig455_023697 {REF} {Length: 552} {NoTransDecoderORF} {RNA1509_11101} {RNA1310_22145} {RNA815_35811}
13. MligTC455_02461 5 0.11 Mlig455_019900

Neo: -

Age: -

 0.98 - - - - 0.980 - Mlig455_019900 {REF} {Length: 253} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135}
14. MligTC455_21884 13 0.27 Mlig455_070568

Neo: -

Age: -

 SRSF7 0.978 - - - - 0.978 - Mlig455_070568 {REF} {Length: 1659} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=59.7]; RNA recognition motif [PF16367.7, score=24.4]; Zinc knuckle [PF00098.25, score=20.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=19.2]} {Human: ENSG00000115875, SRSF7, serine and arginine rich splicing factor 7, [RH, Score=142, Expect=6e-43]} {Mouse: ENSMUSG00000024097, Srsf7, serine/arginine-rich splicing factor 7, [RH, Score=142, Expect=4e-43]} {Dmel: FBgn0260944, Rbp1, RNA-binding protein 1, [RH, Score=102, Expect=2e-27]} {Celegans: WBGene00004703, rsp-6, Probable splicing factor, arginine/serine-rich 6, [Score=103, Expect=7e-28]} {Smed: dd_Smed_v6_2424_0_1, dd_Smed_v6_2424_0_1, [RH, Score=124, Expect=4e-36]} {RNA1509_38744} {RNA1310_52982} {RNA815_7835}
15. MligTC455_04625 54 1.12 Mlig455_031551, Mlig455_031554

Neo: -

Age: -

 FHAD1 0.977 - - - - 0.977 -

Mlig455_031551 {REF} {Length: 1252} {Pfam: FHA domain [PF00498.28, score=38.1]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=33.3]} {Smed: dd_Smed_v6_14350_0_1, dd_Smed_v6_14350_0_1, [Score=66.2, Expect=1e-11]} {RNA1509_11172} {RNA1310_2117.1} {RNA815_31030}

Mlig455_031554 {REF} {Length: 5287} {Pfam: FHA domain [PF00498.28, score=36.7]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=33.0]} {Human: ENSG00000142621, FHAD1, forkhead associated phosphopeptide binding domain 1, [Score=130, Expect=4e-31]} {Mouse: ENSMUSG00000051435, Fhad1, forkhead-associated (FHA) phosphopeptide binding domain 1, [Score=129, Expect=1e-29]; ENSMUSG00000116181, Fhad1, forkhead-associated (FHA) phosphopeptide binding domain 1, [Score=129, Expect=1e-29]} {Smed: dd_Smed_v6_14350_0_1, dd_Smed_v6_14350_0_1, [Score=252, Expect=3e-68]} {RNA1509_11172} {RNA1310_2117.1} {RNA815_6949}
16. MligTC455_17534 40 0.84 Mlig455_004568

Neo: -

Age: Down-Up-Down

Region-enriched R2: 4.609/0.04169

 0.977 - - - - 0.977 - Mlig455_004568 {REF} {Length: 2000} {Pfam: CD20-like family [PF04103.17, score=25.6]} {RNA1509_45188} {RNA1310_19605, RNA1509_45188} {RNA1509_45188, RNA815_13393}
17. MligTC455_41297 10 0.21 Mlig455_015247

Neo: -

Age: -

 0.976 - - - - 0.976 - Mlig455_015247 {REF} {Length: 738} {NoTransDecoderORF}
18. MligTC455_06577 7 0.14 Mlig455_044334

Neo: -

Age: Up-Down-Down

 0.975 - - - - 0.975 - Mlig455_044334 {REF} {Length: 706}
19. MligTC455_23938 109 2.26 Mlig455_044682

Neo: -

Age: logFC(26M/2M)=0.355

 TRPM3 0.975 - - - - 0.975 - Mlig455_044682 {REF} {Length: 6333} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=80.4]; Ankyrin repeats (3 copies) [PF12796.9, score=74.8]; Ankyrin repeat [PF13606.8, score=59.5]; Ion transport protein [PF00520.33, score=57.5]; Ankyrin repeat [PF00023.32, score=51.1]; Ankyrin repeats (many copies) [PF13857.8, score=38.9]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=139, Expect=2e-32]; ENSG00000134160, TRPM1, transient receptor potential cation channel subfamily M member 1, [Score=139, Expect=2e-32]; ENSG00000274965, TRPM1, transient receptor potential cation channel subfamily M member 1, [Score=139, Expect=2e-32]} {Mouse: ENSMUSG00000030523, Trpm1, transient receptor potential cation channel, subfamily M, member 1, [Score=141, Expect=3e-33]; ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=140, Expect=4e-33]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=112, Expect=2e-24]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=111, Expect=2e-24]} {Smed: dd_Smed_v6_8382_0_1, dd_Smed_v6_8382_0_1, [Score=192, Expect=2e-49]} {RNA1509_19611, RNA1509_32799} {RNA1310_1742.1, RNA1509_19611, RNA1509_32799} {RNA1509_19611, RNA1509_32799, RNA815_1771}
20. MligTC455_49878 31 0.65 Mlig455_050656

Neo: -

Age: -

 CHRNA10 0.975 - - - - 0.975 - Mlig455_050656 {REF} {Length: 1810} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.7]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=145, Expect=8e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=7e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=4e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=9e-37]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=143, Expect=9e-38]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=7e-37]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=139, Expect=4e-36]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=134, Expect=3e-34]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=126, Expect=9e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=133, Expect=3e-34]} {RNA1310_26175} {RNA815_7952}
21. MligTC455_13471 12 0.26 Mlig455_065390

Neo: -

Age: -

 0.974 - - - - 0.974 - Mlig455_065390 {REF} {Length: 665} {NoTransDecoderORF} {RNA1509_16969} {RNA1310_51432} {RNA815_47685}
22. MligTC455_30594 23 0.48 Mlig455_038529, Mlig455_052221

Neo: -

Age: -

 0.974 - - - - 0.974 -

Mlig455_038529 {REF} {Length: 805} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=35.1]} {RNA1509_40834} {RNA1310_11051} {RNA815_3523.1}

Mlig455_052221 {REF} {Length: 7356} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=40.2]; Mab-21 protein [PF03281.16, score=18.9]} {RNA1509_14346, RNA1509_40834} {RNA1310_11051, RNA1509_14346} {RNA1509_14346, RNA815_3523.1}
23. MligTC455_47574 716 14.92 Mlig455_028318, Mlig455_066192

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=1.060

Region-enriched R2: 1.667/0.01738

 MAN1C1 0.971 - - - - 0.971 -

Mlig455_028318 {REF} {Length: 2839} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_9530} {RNA1310_9474.1} {RNA815_6962}

Mlig455_066192 {REF} {Length: 2836} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_53617, RNA1509_9530} {RNA1310_9474.1, RNA1509_53617} {RNA1509_53617, RNA815_6962}
24. MligTC455_15053 12 0.26 Mlig455_016326

Neo: -

Age: -

 0.97 - - - - 0.970 - Mlig455_016326 {REF} {Length: 2006} {NoTransDecoderORF} {RNA1509_50409, RNA1509_54815} {RNA1310_146928, RNA1509_50409} {RNA1509_50409, RNA815_32053}
25. MligTC455_09822 5 0.1 Mlig455_017858

Neo: -

Age: -

 0.969 - - - - 0.969 - Mlig455_017858 {REF} {Length: 616} {NoTransDecoderORF} {RNA1310_73710}
26. MligTC455_19695 59 1.23 Mlig455_067848

Neo: -

Age: logFC(26M/2M)=-0.595

 0.969 - - - - 0.969 - Mlig455_067848 {REF} {Length: 1979} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=32.9]} {Smed: dd_Smed_v6_12148_0_3, dd_Smed_v6_12148_0_3, [Score=76.3, Expect=8e-16]} {RNA1509_37281} {RNA1310_6533.1} {RNA815_6407}
27. MligTC455_51200 66 1.37 Mlig455_057090

Neo: -

Age: -

 0.968 - - - - 0.968 - Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272}
28. MligTC455_53286 6 0.13 Mlig455_061308

Neo: -

Age: -

 0.968 - - - - 0.968 - Mlig455_061308 {REF} {Length: 398} {NoTransDecoderORF}
29. MligTC455_35325 26 0.54 Mlig455_008452, Mlig455_031353, Mlig455_056519

Neo: -

Age: -

 HTR3A 0.967 - - - - 0.967 -

Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010}

Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010}

Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010}
30. MligTC455_26562 51 1.05 Mlig455_003821

Neo: -

Age: -

Region-enriched R4: 4.788/0.04787

 0.966 - - - - 0.966 - Mlig455_003821 {REF} {Length: 3329} {NoTransDecoderORF} {RNA1509_310} {RNA1310_3669} {RNA815_20255}
31. MligTC455_31082 93 1.93 Mlig455_020193

Neo: -

Age: Up-Down-Up

 0.965 - - - - 0.965 - Mlig455_020193 {REF} {Length: 1952} {RNA1509_54750} {RNA1310_22843} {RNA815_11564.1}
32. MligTC455_29464 25 0.53 Mlig455_021892

Neo: -

Age: -

 SDCCAG8 0.963 - - - - 0.963 - Mlig455_021892 {REF} {Length: 3036} {Pfam: Centrosomal colon cancer autoantigen protein family [PF15964.7, score=164.7]} {Human: ENSG00000276111, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]; ENSG00000054282, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000026504, Sdccag8, serologically defined colon cancer antigen 8, [RH, Score=109, Expect=4e-24]} {Dmel: FBgn0266566, CG45105, [Score=52.4, Expect=2e-06]} {Smed: dd_Smed_v6_9295_0_2, dd_Smed_v6_9295_0_2, [RH, Score=87.8, Expect=7e-18]} {RNA1509_42574} {RNA1310_5942.1} {RNA815_9353.1}
33. MligTC455_42708 48 1.01 Mlig455_027999, Mlig455_028026

Neo: -

Age: -

 0.963 - - - - 0.963 -

Mlig455_027999 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552}

Mlig455_028026 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552}
34. MligTC455_48125 91 1.9 Mlig455_005602, Mlig455_070397

Neo: -

Age: -

Region-enriched R2: 4.171/0.01740

 0.962 - - - - 0.962 -

Mlig455_005602 {REF} {Length: 2407} {RNA1509_6760} {RNA1310_2628} {RNA815_4402}

Mlig455_070397 {REF} {Length: 2447} {RNA1509_6760} {RNA1310_132399} {RNA815_4402}
35. MligTC455_05979 11 0.23 Mlig455_067718

Neo: -

Age: -

 0.961 - - - - 0.961 - Mlig455_067718 {REF} {Length: 1018} {RNA1509_2330} {RNA1310_37520} {RNA815_22367}
36. MligTC455_51123 37 0.77 Mlig455_059507

Neo: -

Age: -

 0.961 - - - - 0.961 - Mlig455_059507 {REF} {Length: 970} {RNA1310_88282}
37. MligTC455_35116 13 0.27 Mlig455_049393

Neo: -

Age: -

 RSBN1L 0.96 - - - - 0.960 - Mlig455_049393 {REF} {Length: 1687} {TRANSSPLICED} {Human: ENSG00000187257, RSBN1L, round spermatid basic protein 1 like, [RH, Score=291, Expect=2e-88]; ENSG00000081019, RSBN1, round spermatid basic protein 1, [RH, Score=286, Expect=2e-87]} {Mouse: ENSMUSG00000039968, Rsbn1l, round spermatid basic protein 1-like, [RH, Score=292, Expect=3e-89]; ENSMUSG00000044098, Rsbn1, rosbin, round spermatid basic protein 1, [RH, Score=285, Expect=6e-87]} {Dmel: FBgn0032717, CG10600, [RH, Score=276, Expect=4e-81]} {Celegans: WBGene00001080, dpy-21, Dosage compensation protein dpy-21, [RH, Score=232, Expect=6e-66]} {Smed: dd_Smed_v6_4605_0_1, dd_Smed_v6_4605_0_1, [RH, Score=391, Expect=1e-130]} {RNA1509_10039} {RNA1310_18364, RNA1509_10039} {RNA1509_10039, RNA815_7365}
38. MligTC455_00072 10 0.2 Mlig455_001911

Neo: -

Age: -

 0.959 - - - - 0.959 - Mlig455_001911 {REF} {Length: 296} {NoTransDecoderORF} {RNA1310_118235}
39. MligTC455_24786 300 6.25 Mlig455_032143, Mlig455_049302

Neo: -

Age: logFC(26M/2M)=-0.528

 0.959 - - - - 0.959 -

Mlig455_032143 {REF} {Length: 358} {NoTransDecoderORF} {RNA1509_36687} {RNA1310_1894} {RNA815_5614.1}

Mlig455_049302 {REF} {Length: 3378} {Pfam: PT repeat [PF04886.14, score=51.8]} {RNA1509_45844} {RNA1310_12902.2} {RNA815_515.1}
40. MligTC455_40989 801 16.68 Mlig455_016294

Neo: -

Age: logFC(26M/2M)=0.270

 PKD2 0.959 - - - - 0.959 - Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677}
41. MligTC455_40395 12 0.26 Mlig455_047575, Mlig455_069695

Neo: -

Age: -

 0.957 - - - - 0.957 -

Mlig455_047575 {REF} {Length: 854} {NoTransDecoderORF} {RNA1310_129563}

Mlig455_069695 {REF} {Length: 620} {NoTransDecoderORF} {RNA1310_129563}
42. MligTC455_44444 123 2.57 Mlig455_062758

Neo: -

Age: -

 0.957 - - - - 0.957 - Mlig455_062758 {REF} {Length: 1304} {Pfam: Retinal tissue protein [PF10044.11, score=28.1]} {RNA1509_3524} {RNA1310_10649.1} {RNA815_4708.1}
43. MligTC455_32222 6 0.13 Mlig455_068777

Neo: -

Age: Down-Up-Down

 0.956 - - - - 0.956 - Mlig455_068777 {REF} {Length: 1563} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.2]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=55.5, Expect=1e-08]} {RNA1509_41917} {RNA1310_24082} {RNA815_13028}
44. MligTC455_52462 166 3.45 Mlig455_005943

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=4.076

Regeneration-upregulated R2: 5.759

Regeneration-enriched R2: 5.759

 AGRN 0.956 - - - - 0.956 - Mlig455_005943 {REF} {Length: 1577} {Pfam: Kazal-type serine protease inhibitor domain [PF00050.23, score=130.4]; Kazal-type serine protease inhibitor domain [PF07648.17, score=91.6]} {Human: ENSG00000188157, AGRN, agrin, [Score=55.8, Expect=8e-08]} {Mouse: ENSMUSG00000041936, Agrn, agrin, [Score=56.2, Expect=4e-08]} {Dmel: FBgn0052354, CG32354, [Score=48.1, Expect=9e-06]} {Smed: dd_Smed_v6_3649_0_1, dd_Smed_v6_3649_0_1, [Score=51.6, Expect=5e-07]} {RNA1509_43736} {RNA1310_19594} {RNA815_11515}
45. MligTC455_10204 14 0.29 Mlig455_049702, Mlig455_049708

Neo: -

Age: -

 0.955 - - - - 0.955 -

Mlig455_049702 {REF} {Length: 217} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_47324} {RNA815_43123}

Mlig455_049708 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_57782} {RNA815_43123}
46. MligTC455_13130 40 0.83 Mlig455_032511, Mlig455_068691

Neo: -

Age: -

 WSCD2 0.955 - - - - 0.955 -

Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067}

Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067}
47. MligTC455_33875 32 0.67 Mlig455_039631

Neo: -

Age: -

 0.955 - - - - 0.955 - Mlig455_039631 {REF} {Length: 3055} {TRANSSPLICED} {RNA1509_14655, RNA1509_53977} {RNA1310_22046.1, RNA1509_53977} {RNA1509_53977, RNA815_8738}
48. MligTC455_01582 43 0.89 Mlig455_046055

Neo: -

Age: -

 0.954 - - - - - 0.954 Mlig455_046055 {REF} {Length: 504} {NoTransDecoderORF} {RNA1509_284} {RNA1310_24413} {RNA815_6153}
49. MligTC455_10303 18 0.37 Mlig455_046266, Mlig455_061552

Neo: -

Age: Up-Down-Down

 0.954 - - - - 0.954 -

Mlig455_046266 {REF} {Length: 471} {NoTransDecoderORF} {RNA1509_39059} {RNA1310_16810} {RNA815_14408}

Mlig455_061552 {REF} {Length: 293} {NoTransDecoderORF} {RNA1509_39059} {RNA1310_16810} {RNA815_14408}
50. MligTC455_25410 47 0.97 Mlig455_026185

Neo: -

Age: Up-Down-Down

Region-enriched R2: 8.036/0.00469
Region-enriched R6: 6.422/0.01487

 0.953 - - - - 0.953 - Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868}
51. MligTC455_24515 14 0.28 Mlig455_033346, Mlig455_033365

Neo: -

Age: -

 HTR1B 0.952 - - - - 0.952 -

Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724}

Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724}
52. MligTC455_26981 5 0.1 Mlig455_011800

Neo: -

Age: -

 0.952 - - - - 0.952 - Mlig455_011800 {REF} {Length: 425} {TRANSSPLICED} {Pfam: Regulatory subunit of type II PKA R-subunit [PF02197.19, score=39.6]} {Smed: dd_Smed_v6_4783_0_72, dd_Smed_v6_4783_0_72, [Score=54.3, Expect=2e-09]} {RNA1310_101144}
53. MligTC455_31210 51 1.07 Mlig455_028581

Neo: -

Age: Down-Up-Down

 KCNH7 0.952 - - - - 0.952 - Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478}
54. MligTC455_47244 216 4.49 Mlig455_016130

Neo: -

Age: -

Region-enriched R2: 3.391/0.02151
Region-enriched R6: 2.922/0.03099

 0.952 - - - - 0.952 - Mlig455_016130 {REF} {Length: 3312} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=27.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.5]} {Smed: dd_Smed_v6_24733_0_1, dd_Smed_v6_24733_0_1, [RH, Score=231, Expect=1e-71]} {RNA1509_41111} {RNA1310_18481.1} {RNA815_10445}
55. MligTC455_36184 21 0.44 Mlig455_047420

Neo: -

Age: -

 0.951 - - - - 0.951 - Mlig455_047420 {REF} {Length: 487} {NoTransDecoderORF} {RNA1509_14659} {RNA1310_107234} {RNA815_14343.7}
56. MligTC455_38926 75 1.56 Mlig455_036654

Neo: -

Age: -

 0.951 - - - - 0.951 - Mlig455_036654 {REF} {Length: 654} {TRANSSPLICED} {RNA1509_25556} {RNA1310_11387.2} {RNA815_48752}
57. MligTC455_53394 4109 85.59 Mlig455_047970

Neo: -

Age: Up-Down-Down

Regeneration-downregulated R3: -3.745

Regeneration-depleted R3: -3.745

 AC099489.1 0.951 - - - - - 0.951 Mlig455_047970 {REF} {Length: 12677} {Pfam: Lipoprotein amino terminal region [PF01347.24, score=204.5]; Domain of unknown function (DUF1943) [PF09172.13, score=111.1]; von Willebrand factor type D domain [PF00094.27, score=43.6]} {Human: ENSG00000188897, AC099489.1, vitellogenin, [Score=171, Expect=3e-41]} {Mouse: ENSMUSG00000020609, Apob, apolipoprotein B, [Score=94.0, Expect=5e-18]} {Dmel: FBgn0032136, Apoltp, Apolipoprotein lipid transfer particle, [Score=154, Expect=2e-36]} {Smed: dd_Smed_v6_636_0_1, dd_Smed_v6_636_0_1, [Score=178, Expect=4e-44]} {RNA1509_22} {RNA1310_66} {RNA815_31.1}
58. MligTC455_19888 22 0.46 Mlig455_066525

Neo: -

Age: -

 AC254952.1 0.95 - - - - 0.950 - Mlig455_066525 {REF} {Length: 1890} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=188.2]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=20.4]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=188, Expect=5e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=185, Expect=4e-56]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=195, Expect=4e-58]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=242, Expect=1e-75]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=175, Expect=7e-51]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=228, Expect=9e-71]} {RNA1310_34222.1} {RNA815_33884}
59. MligTC455_26983 19 0.39 Mlig455_013027, Mlig455_013057, Mlig455_013074

Neo: -

Age: Up-Down-Up

 ANKRD11 0.95 - - - - 0.950 -

Mlig455_013027 {REF} {Length: 5928} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=66.0]; Ankyrin repeat [PF00023.32, score=41.8]; Ankyrin repeat [PF13606.8, score=41.0]; Ankyrin repeats (many copies) [PF13857.8, score=39.5]; Mab-21 protein [PF03281.16, score=34.4]; Ankyrin repeats (many copies) [PF13637.8, score=30.5]} {Human: ENSG00000167522, ANKRD11, ankyrin repeat domain 11, [Score=52.4, Expect=9e-06]} {Mouse: ENSMUSG00000035569, Ankrd11, ankyrin repeat domain 11, [Score=55.1, Expect=8e-07]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=54.3, Expect=1e-06]} {RNA1509_2705} {RNA1310_4888.2} {RNA815_10746}

Mlig455_013057 {REF} {Length: 434} {Pfam: Regulatory subunit of type II PKA R-subunit [PF02197.19, score=39.3]} {Smed: dd_Smed_v6_4783_0_58, dd_Smed_v6_4783_0_58, [Score=53.9, Expect=3e-09]} {RNA1310_101144}

Mlig455_013074 {REF} {Length: 431} {Pfam: Regulatory subunit of type II PKA R-subunit [PF02197.19, score=39.3]} {Smed: dd_Smed_v6_4783_0_64, dd_Smed_v6_4783_0_64, [Score=53.9, Expect=3e-09]} {RNA1310_101144}
60. MligTC455_49214 6 0.13 Mlig455_068565

Neo: -

Age: -

 0.95 - - - - 0.950 - Mlig455_068565 {REF} {Length: 1544} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=105.5]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=53.1, Expect=3e-08]} {RNA1310_27155} {RNA815_39321}
61. MligTC455_49875 59 1.22 Mlig455_027217

Neo: -

Age: -

 0.95 - - - - 0.950 - Mlig455_027217 {REF} {Length: 1809} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.9]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=64.7, Expect=5e-12]} {Celegans: WBGene00008997, lgc-31, Ligand-Gated ion Channel, [Score=70.9, Expect=3e-14]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=67.0, Expect=6e-13]} {RNA1310_26175} {RNA815_7952}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA